Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Europe Alpha-1 Antitrypsin Drugs Sales Market Report 2021

  • QYR679885
  • 105 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
This report studies sales (consumption) of Alpha-1 Antitrypsin Drugs in Europe market, especially in Germany, UK, France, Italy, Spain and Russia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Baxter International

CSL Behring

Grifols

Kamada

Abeona Therapeutics

Alnylam Pharmaceuticals

Applied Genetic Technologies

Arrowhead Research

Baxalta

Shanghai Shensuo

Chiesi

Curaxys

ProBioGen

ProMetic Life Sciences

Ningbo Yijie

Market Segment by Regions, this report splits Europe into several key Regions, with sales (consumption), revenue, market share and growth rate of Alpha-1 Antitrypsin Drugs in these regions, from 2011 to 2021 (forecast), like

Germany

France

UK

Italy

Spain

Russia

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Alpha-1 Antitrypsin Drugs in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

1 Alpha-1 Antitrypsin Drugs Overview

1.1 Product Overview and Scope of Alpha-1 Antitrypsin Drugs

1.2 Classification of Alpha-1 Antitrypsin Drugs

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Applications of Alpha-1 Antitrypsin Drugs

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Alpha-1 Antitrypsin Drugs Market by Regions

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Italy Status and Prospect (2011-2021)

1.4.5 Spain Status and Prospect (2011-2021)

1.4.6 Russia Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Alpha-1 Antitrypsin Drugs (2011-2021)

1.5.1 Europe Alpha-1 Antitrypsin Drugs Sales, Revenue and Price (2011-2021)

1.5.2 Europe Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

1.5.3 Europe Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

2 Europe Alpha-1 Antitrypsin Drugs by Manufacturers, Type and Application

2.1 Europe Alpha-1 Antitrypsin Drugs Market Competition by Manufacturers

2.1.1 Europe Alpha-1 Antitrypsin Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Alpha-1 Antitrypsin Drugs (Volume and Value) by Type

2.2.1 Europe Alpha-1 Antitrypsin Drugs Sales and Market Share by Type (2011-2021)

2.2.2 Europe Alpha-1 Antitrypsin Drugs Revenue and Market Share by Type (2011-2021)

2.3 Europe Alpha-1 Antitrypsin Drugs (Volume and Value) by Regions

2.3.1 Europe Alpha-1 Antitrypsin Drugs Sales and Market Share by Regions (2011-2021)

2.3.2 Europe Alpha-1 Antitrypsin Drugs Revenue and Market Share by Regions (2011-2021)

2.4 Europe Alpha-1 Antitrypsin Drugs (Volume) by Application

3 Germany Alpha-1 Antitrypsin Drugs (Volume, Value and Sales Price)

3.1 Germany Alpha-1 Antitrypsin Drugs Sales and Value (2011-2021)

3.1.1 Germany Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

3.1.2 Germany Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

3.1.3 Germany Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

3.2 Germany Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturers

3.3 Germany Alpha-1 Antitrypsin Drugs Sales and Market Share by Type

3.4 Germany Alpha-1 Antitrypsin Drugs Sales and Market Share by Applications

4 UK Alpha-1 Antitrypsin Drugs (Volume, Value and Sales Price)

4.1 UK Alpha-1 Antitrypsin Drugs Sales and Value (2011-2021)

4.1.1 UK Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

4.1.2 UK Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

4.1.3 UK Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

4.2 UK Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturers

4.3 UK Alpha-1 Antitrypsin Drugs Sales and Market Share by Type

4.4 UK Alpha-1 Antitrypsin Drugs Sales and Market Share by Applications

5 France Alpha-1 Antitrypsin Drugs (Volume, Value and Sales Price)

5.1 France Alpha-1 Antitrypsin Drugs Sales and Value (2011-2021)

5.1.1 France Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

5.1.2 France Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

5.1.3 France Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

5.2 France Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturers

5.3 France Alpha-1 Antitrypsin Drugs Sales and Market Share by Type

5.4 France Alpha-1 Antitrypsin Drugs Sales and Market Share by Applications

6 Italy Alpha-1 Antitrypsin Drugs (Volume, Value and Sales Price)

6.1 Italy Alpha-1 Antitrypsin Drugs Sales and Value (2011-2021)

6.1.1 Italy Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

6.1.2 Italy Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

6.1.3 Italy Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

6.2 Italy Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturers

6.3 Italy Alpha-1 Antitrypsin Drugs Sales and Market Share by Type

6.4 Italy Alpha-1 Antitrypsin Drugs Sales and Market Share by Applications

7 Russia Alpha-1 Antitrypsin Drugs (Volume, Value and Sales Price)

7.1 Russia Alpha-1 Antitrypsin Drugs Sales and Value (2011-2021)

7.1.1 Russia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

7.1.2 Russia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

7.1.3 Russia Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

7.2 Russia Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturers

7.3 Russia Alpha-1 Antitrypsin Drugs Sales and Market Share by Type

7.4 Russia Alpha-1 Antitrypsin Drugs Sales and Market Share by Applications

8 Spain Alpha-1 Antitrypsin Drugs (Volume, Value and Sales Price)

8.1 Spain Alpha-1 Antitrypsin Drugs Sales and Value (2011-2021)

8.1.1 Spain Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

8.1.2 Spain Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

8.1.3 Spain Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

8.2 Spain Alpha-1 Antitrypsin Drugs Sales and Market Share by Manufacturers

8.3 Spain Alpha-1 Antitrypsin Drugs Sales and Market Share by Type

8.4 Spain Alpha-1 Antitrypsin Drugs Sales and Market Share by Applications

9 Europe Alpha-1 Antitrypsin Drugs Manufacturers Analysis

9.1 Baxter International

9.1.1 Company Basic Information,Manufacturing Base and Competitors

9.1.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Baxter International (2015 and 2016)

9.2 CSL Behring

9.2.1 Company Basic Information,Manufacturing Base and Competitors

9.2.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of CSL Behring (2015 and 2016)

9.3 Grifols

9.3.1 Company Basic Information,Manufacturing Base and Competitors

9.3.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Grifols (2015 and 2016)

9.4 Kamada

9.4.1 Company Basic Information,Manufacturing Base and Competitors

9.4.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Kamada (2015 and 2016)

9.5 Abeona Therapeutics

9.5.1 Company Basic Information,Manufacturing Base and Competitors

9.5.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Abeona Therapeutics (2015 and 2016)

9.6 Alnylam Pharmaceuticals

9.6.1 Company Basic Information,Manufacturing Base and Competitors

9.6.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Alnylam Pharmaceuticals (2015 and 2016)

9.7 Applied Genetic Technologies

9.7.1 Company Basic Information,Manufacturing Base and Competitors

9.7.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Applied Genetic Technologies (2015 and 2016)

9.8 Arrowhead Research

9.8.1 Company Basic Information,Manufacturing Base and Competitors

9.8.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Arrowhead Research (2015 and 2016)

9.9 Baxalta

9.9.1 Company Basic Information,Manufacturing Base and Competitors

9.9.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Baxalta (2015 and 2016)

9.10 Shanghai Shensuo

9.10.1 Company Basic Information,Manufacturing Base and Competitors

9.10.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Shanghai Shensuo (2015 and 2016)

9.11 Chiesi

9.11.1 Company Basic Information,Manufacturing Base and Competitors

9.11.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.11.2.1 Type I

9.11.2.2 Type II

9.11.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Chiesi (2015 and 2016)

9.12 Curaxys

9.12.1 Company Basic Information,Manufacturing Base and Competitors

9.12.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.12.2.1 Type I

9.12.2.2 Type II

9.12.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Curaxys (2015 and 2016)

9.13 ProBioGen

9.13.1 Company Basic Information,Manufacturing Base and Competitors

9.13.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.13.2.1 Type I

9.13.2.2 Type II

9.13.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of ProBioGen (2015 and 2016)

9.14 ProMetic Life Sciences

9.14.1 Company Basic Information,Manufacturing Base and Competitors

9.14.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.14.2.1 Type I

9.14.2.2 Type II

9.14.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of ProMetic Life Sciences (2015 and 2016)

9.15 Ningbo Yijie

9.15.1 Company Basic Information,Manufacturing Base and Competitors

9.15.2 Alpha-1 Antitrypsin Drugs Product Type and Technology

9.15.2.1 Type I

9.15.2.2 Type II

9.15.3 Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Ningbo Yijie (2015 and 2016)

10 Alpha-1 Antitrypsin Drugs Technology and Development Trend

10.1 Alpha-1 Antitrypsin Drugs Technology Analysis

10.2 Alpha-1 Antitrypsin Drugs Technology Development Trend

11 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Alpha-1 Antitrypsin Drugs

Table Classification of Alpha-1 Antitrypsin Drugs

Figure Europe Sales Market Share of Alpha-1 Antitrypsin Drugs by Types in 2015

Table Applications of Alpha-1 Antitrypsin Drugs

Figure Europe Sales Market Share of Alpha-1 Antitrypsin Drugs by Applications in 2015

Figure Germany Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure France Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure UK Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales, Revenue and Price (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales of Key Manufacturers (2015 and 2016)

Table Europe Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers

Figure 2016 Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers

Table Europe Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2015 and 2016)

Table Europe Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers

Table 2016 Europe Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers

Table Europe Alpha-1 Antitrypsin Drugs Sales and Market Share by Type (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales Share by Type (2011-2021)

Figure Sales Market Share of Alpha-1 Antitrypsin Drugs by Type (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate by Type (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Revenue and Market Share by Type (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Alpha-1 Antitrypsin Drugs by Type (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate by Type (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales and Market Share by Regions (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales Share by Regions (2011-2021)

Figure Sales Market Share of Alpha-1 Antitrypsin Drugs by Regions (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate by Regions (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Revenue and Market Share by Regions (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Revenue Share by Regions (2011-2021)

Figure Revenue Market Share of Alpha-1 Antitrypsin Drugs by Regions (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate by Regions (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales and Market Share by Application (2011-2021)

Table Europe Alpha-1 Antitrypsin Drugs Sales Share by Application (2011-2021)

Figure Sales Market Share of Alpha-1 Antitrypsin Drugs by Application (2011-2021)

Figure Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate by Application (2011-2021)

Figure Germany Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure Germany Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Germany Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

Table Germany Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015 and 2016)

Table Germany Alpha-1 Antitrypsin Drugs Market Share by Manufacturers (2015 and 2016)

Table Germany Alpha-1 Antitrypsin Drugs Sales by Type (2015 and 2016)

Table Germany Alpha-1 Antitrypsin Drugs Market Share by Type (2015 and 2016)

Table Germany Alpha-1 Antitrypsin Drugs Sales by Applications (2015 and 2016)

Table Germany Alpha-1 Antitrypsin Drugs Market Share by Applications (2015 and 2016)

Figure UK Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure UK Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure UK Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

Table UK Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015 and 2016)

Table UK Alpha-1 Antitrypsin Drugs Market Share by Manufacturers (2015 and 2016)

Table UK Alpha-1 Antitrypsin Drugs Sales by Type (2015 and 2016)

Table UK Alpha-1 Antitrypsin Drugs Market Share by Type (2015 and 2016)

Table UK Alpha-1 Antitrypsin Drugs Sales by Applications (2015 and 2016)

Table UK Alpha-1 Antitrypsin Drugs Market Share by Applications (2015 and 2016)

Figure France Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure France Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure France Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

Table France Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015 and 2016)

Table France Alpha-1 Antitrypsin Drugs Market Share by Manufacturers (2015 and 2016)

Table France Alpha-1 Antitrypsin Drugs Sales by Type (2015 and 2016)

Table France Alpha-1 Antitrypsin Drugs Market Share by Type (2015 and 2016)

Table France Alpha-1 Antitrypsin Drugs Sales by Applications (2015 and 2016)

Table France Alpha-1 Antitrypsin Drugs Market Share by Applications (2015 and 2016)

Figure Italy Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure Italy Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Italy Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

Table Italy Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015 and 2016)

Table Italy Alpha-1 Antitrypsin Drugs Market Share by Manufacturers (2015 and 2016)

Table Italy Alpha-1 Antitrypsin Drugs Sales by Type (2015 and 2016)

Table Italy Alpha-1 Antitrypsin Drugs Market Share by Type (2015 and 2016)

Table Italy Alpha-1 Antitrypsin Drugs Sales by Applications (2015 and 2016)

Table Italy Alpha-1 Antitrypsin Drugs Market Share by Applications (2015 and 2016)

Figure Russia Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure Russia Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Russia Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

Table Russia Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015 and 2016)

Table Russia Alpha-1 Antitrypsin Drugs Market Share by Manufacturers (2015 and 2016)

Table Russia Alpha-1 Antitrypsin Drugs Sales by Type (2015 and 2016)

Table Russia Alpha-1 Antitrypsin Drugs Market Share by Type (2015 and 2016)

Table Russia Alpha-1 Antitrypsin Drugs Sales by Applications (2015 and 2016)

Table Russia Alpha-1 Antitrypsin Drugs Market Share by Applications (2015 and 2016)

Figure Spain Alpha-1 Antitrypsin Drugs Sales and Growth Rate (2011-2021)

Figure Spain Alpha-1 Antitrypsin Drugs Revenue and Growth Rate (2011-2021)

Figure Spain Alpha-1 Antitrypsin Drugs Sales Price Trend (2011-2021)

Table Spain Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015 and 2016)

Table Spain Alpha-1 Antitrypsin Drugs Market Share by Manufacturers (2015 and 2016)

Table Spain Alpha-1 Antitrypsin Drugs Sales by Type (2015 and 2016)

Table Spain Alpha-1 Antitrypsin Drugs Market Share by Type (2015 and 2016)

Table Spain Alpha-1 Antitrypsin Drugs Sales by Applications (2015 and 2016)

Table Spain Alpha-1 Antitrypsin Drugs Market Share by Applications (2015 and 2016)

Table Baxter International Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Baxter International (2015 and 2016)

Table CSL Behring Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of CSL Behring (2015 and 2016)

Table Grifols Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Grifols (2015 and 2016)

Table Kamada Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Kamada (2015 and 2016)

Table Abeona Therapeutics Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Abeona Therapeutics (2015 and 2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Alnylam Pharmaceuticals (2015 and 2016)

Table Applied Genetic Technologies Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Applied Genetic Technologies (2015 and 2016)

Table Arrowhead Research Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Arrowhead Research (2015 and 2016)

Table Baxalta Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Baxalta (2015 and 2016)

Table Shanghai Shensuo Basic Information List

Table Alpha-1 Antitrypsin Drugs Sales, Revenue, Price of Shanghai Shensuo (2015 and 2016)

...

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390